Page 4 - உலகளாவிய தடுப்பூசி உச்சிமாநாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Secretary-General Calls Vaccine Equity Biggest Moral Test for Global Community, as Security Council Considers Equitable Availability of Doses - World

Secretary-General Calls Vaccine Equity Biggest Moral Test for Global Community, as Security Council Considers Equitable Availability of Doses Format SC/14438 Addressing the equitable distribution of vaccines against the coronavirus in the Security Council today, United Nations Secretary-General António Guterres proposed the creation of an emergency task force by the G20 countries to prepare and help implement a global immunization plan. “The rollout of COVID-19 vaccines is generating hope,” he told the 15-member Council’s videoconferencing meeting. “At this critical moment, vaccine equity is the biggest moral test before the global community.” Today’s meeting was organized to discuss the role of the Security Council, Member States and the United Nations in ensuring that vaccines are made available equitably in places affected by conflict and insecurity.

United statesDemocratic republic of the congoUnited kingdomSaint vincent and the grenadinesRepublic ofCentral african republicSaint vincentRussian federationPham binh minhJagan chapagainMarcelo ebrard casaubonSubrahmanyam jaishankarDominic raabRalphe gonsalvesFranck riesterRaychelle omamo

Ensuring equitable access to COVID-19 vaccines in contexts affected by conflict and insecurity

At the UN Security Council, the Foreign Secretary proposed a new Resolution on temporary ceasefires and coordinated effort for COVID-19 vaccine distribution.

United kingdomDominic raabSecurity council resolutionResolution for the councilUn security councilSecurity councilUnited kingdom foreign secretary dominic raabGlobal vaccine summitஒன்றுபட்டது கிஂக்டம்ஆதிக்கம் செலுத்தும் ராப்பாதுகாப்பு சபை தீர்மானம்தீர்மானம் க்கு தி சபைஐ நா பாதுகாப்பு சபைபாதுகாப்பு சபைஒன்றுபட்டது கிஂக்டம் வெளிநாட்டு செயலாளர் ஆதிக்கம் செலுத்தும் ராப்உலகளாவிய தடுப்பூசி உச்சிமாநாடு

Lessons from India s jab rollout

Lessons from India s jab rollout 17 published : 29 Jan 2021 at 04:00 17 In just 12 days after India launched its Covid-19 vaccination programme on Jan 16 touted as the world s largest coronavirus jab rollout more than 2.3 million healthcare workers have been inoculated against the virus. In Phase I of the drive, India plans to vaccinate some 30 million healthcare and frontline workers. For India, such large-scale vaccinations are not new. Every year, 27 million infants are immunised against 12 diseases. The government s polio immunisation drive, which successfully eradicated the disease from India, has even set the global standard for such programmes. Worth noting is the fact that the two Covid-19 vaccines authorised for emergency use in the country are domestically manufactured the AstraZeneca/Oxford-developed Covishield, which is produced by the Serum Institute of India; and Covaxin, developed indigenously by Bharat Biotech and the Indian C

United statesSri lankaZydus cadilaVasudhaiva kutumbakamNarendra modiAsean covidIndian department of biotechnologyNational biopharma missionNational immunogenicity biologics evaluation centreIndian council for medical researchWorld health organizationMelinda gates foundationWorld bankMission covid surakshaImmunoassay laboratory of the translational health scienceTechnology institute

India reinforces its reputation as the pharmacy of the world

RIYADH: On Jan. 16, Indian Prime Minister Narendra Modi launched the world’s largest coronavirus vaccination program in India. Its target is to inoculate 300 million people by August 2021. More than a million received their first dose within a week of the launch. Over the past several months, more than 30 Indian groups from academia and industry have been involved in the development, collaboration and trials of the COVID-19 vaccines in India. Six vaccine candidates, including three indigenously developed ones, have reached the clinical stages of development. Two vaccines Covishield, licensed from AstraZeneca and Oxford University and produced by the Serum Institute of India, and Covaxin, indigenously developed by Bharat Biotech in partnership with the Indian Council of Medical Research (ICMR) have been approved for emergency use in the country.

Saudi arabiaAr riyaNarendra modiAtmanirbhar bharatUs national institute of healthIndo us vaccine action programIndian council of medical researchDepartment of biotechnologySerum instituteSerum institute of indiaOxford universityIndian prime minister narendra modiBharat biotechIndian councilMedical researchPune based serum institute

SARS-2 Bio-Weapon & Gold Vaccines From CIA-WHO Tests funded by Gates to EU Summit with Pfizer, Biden s sponsor, before Pandemic! – Veterans Today | Military Foreign Affairs Policy Journal for Clandestine Services

SARS-2 Bio-Weapon & Gold Vaccines From CIA-WHO Tests funded by Gates to EU Summit with Pfizer, Biden s sponsor, before Pandemic! – Veterans Today | Military Foreign Affairs Policy Journal for Clandestine Services
veteranstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from veteranstoday.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongUnited kingdomNew york stock exchangeNew yorkSri lankaLos angelesBellevue hospital centerSouth africaEastern capeBruxelles capitaleCity ofRift valleyChapell hillIslamic republic of iranJoe biden